DeviceTalks Boston has ended

Sign up or log in to bookmark your favorites and sync them to your phone or calendar.

Wednesday, June 17


Registration opens
Enjoy refreshments, connect with colleagues and peers after you check in at DeviceTalks. 

Wednesday June 17, 2015 3:30pm - 4:00pm
Boston Scientific Global Headquarters


Creating a Culture for Spectacular Performance

Culture is an organization's expression of itself. It's the living, breathing DNA that delivers on the brand promise — or not.  The first way your customers experience your organization, for example, is usually through the sales force.  Culture is intangible, but it's as real as that first impression.  Like a first impression, you can just let it happen, or you can be intentional about creating it.


Corporate culture is defined by its leadership. When the mission and vision exist merely as statements in the annual report, or platitudes that are framed and hung in the lobby, they're just that: Words. When those core tenets are purposefully aligned throughout the organization - from the boardroom to the sales team to the loading dock - it’s reflected in performance.  And performance is everything.


In the C-suite, the company looks to you to set the bar. What is your vision for the company and why does it exist? Is it shared by all stakeholders? Is your vision worthy of peoples’ time, attention, and dedication? Are you "living the brand"?


If you're not in the C-suite, act like you are. The same principles of leadership apply whether you're managing a team of ten or ten thousand. Either way, you can create a culture of spectacular performance.


In this seminar, J29 Associates will lead a discussion on how to optimize resources so that every person and every process is working at peak effectiveness toward common goals. Whether you're assuming a new role, building the bench, or breathing new life into an existing team, we’ll discuss how to deliver a consistent ROI to your stakeholders while developing an environment of personal satisfaction and professional reward.


avatar for Jackie Gonzalez

Jackie Gonzalez

CEO, J29 Associates
Jackie Gonzalez is a strategic advisor, speaker, and author who optimizes resources to create a culture for spectacular performance. With over 20 years of VP and C- level corporate leadership experience in Sales, Marketing, Business Development, and Organizational Development, Jackie... Read More →

avatar for Lisa Considine

Lisa Considine

Director, HR Business Partner, Boston Scientific Corp.
avatar for Michael Phalen

Michael Phalen

Executive Vice President, President, Medical-Surgery, Boston Scientific
Michael Phalen is Executive Vice President and President, Medical Surgery (MedSurg) for Boston Scientific and a member of its Executive Committee. In this role, he plans and executes Boston Scientific’s growth strategies for the Company’s Endoscopy, Urology/Women’s Health and... Read More →

Wednesday June 17, 2015 4:00pm - 5:30pm
Boston Scientific Global Headquarters


Hot Topics: M&A Megadeals, IP, Financing, and Product Liability Trends for MedTech Companies

·         M&A trends from the perspective of both acquirer and seller

·         IP protection is key to a successful exit

·         Financing best practices from early stage to exit

·         Products liability litigation - what every medtech company needs to know

avatar for David  Dykeman

David Dykeman

Shareholder; Co-Chair, Medical Technology, Greenberg Traurig
David Dykeman, who co-chairs the firm's global Life Sciences & Medical Technology group, is a registered patent attorney with nearly 20 years of experience in patent and intellectual property law. David's practice focuses on securing worldwide intellectual property protection... Read More →

avatar for Charlie Attlan

Charlie Attlan

Vice President, Head of Corporate Business Development and Portfolio, Boston Scientific
Charlie is Vice President, Corporate Business Development for Boston Scientific. He joined the company in 2010, and his team is responsible for coordinating the identification, assessment and execution of business development transactions including acquisitions, VC/minority investments... Read More →
avatar for Jed Cohen

Jed Cohen

Managing Director, Leerink Partners
Jed Cohen joined Leerink Partners as a Managing Director in 2009 to cover the medical technology sector. Jed has over 20 years of Healthcare Investment Banking experience, including 12 years at Citigroup and three years at UBS prior to joining Leerink. Jed’s transaction experience... Read More →
avatar for Tim Johnston

Tim Johnston

Of Counsel, Greenberg Traurig LLP
Tim Johnston is a products liability litigator.  He has defended manufacturers of a wide range of products, including medical devices (such as transvaginal mesh and knee, hip and spine implants), pharmaceuticals, cigarettes, and asbestos-containing products, in federal and state... Read More →

Jeff Mann

Senior Managing Counsel, Med-Surg, Boston Scientific
avatar for David Peck

David Peck

M&A attorney and Shareholder, Greenberg Traurig LLP
David C. Peck works with emerging growth companies, established entities and private equity firms in executing their strategic plans. He assists companies beginning with corporate formation, obtaining and structuring both equity and debt financing, mergers and acquisitions, as well... Read More →

Wednesday June 17, 2015 4:00pm - 5:30pm
Boston Scientific Global Headquarters


How can we collaboratively create value as an industry? A product development workshop
In the midst of big changes in healthcare, with a focus on improving patient outcomes and promoting cost efficiency, how can we collaboratively create value as an industry? Join experts from Boston Scientific, Philips Healthcare and NxStage Medical for this 90 minute brainstorming and networking workshop. In this energized workshop you will have the opportunity to: Gain visibility into the challenges that must be solved by us as an industry in the short term
  •  Learn about industry partnerships and mergers that will reshape the landscape of healthcare
  • Establish an understanding of the innovative technologies created by the merger of current technologies and best practices 
  • Brainstorm with peers to evaluate and co-create potential industry changing concepts
  • Energize your business ecosystem by collaborating with potential partners

avatar for Jeff Champagne

Jeff Champagne

Director, Business Development, MPR Product Development
With a background in R&D and Marketing, Jeff Champagne has a decade of product development experience. Focused on Life Sciences but crossing over multiple industries including Biotech, Medical Device, Energy, Advanced Materials, Specialty Chemistry, Food & Beverage, and Consumer Products... Read More →
avatar for Eric Claude

Eric Claude

Vice President, MPR Product Development
Eric Claude is the Vice President of MPR’s Product Development Group, providing contract product development services for medical device, biopharmaceutical, and other life science firms. His areas of expertise include organizational leadership, business process improvements, personnel... Read More →

Wednesday June 17, 2015 4:00pm - 5:30pm
Boston Scientific Global Headquarters


Regulatory Session: Maximizing Your Clinical Investment
Regulatory/Clinical Session: Maximizing Your Clinical InvestmentIndustry Thought Leaders will discuss utilizing clinical, regulatory, and scientific communication strategies to get the most out of your clinical investment. Panelists will discuss using a multi-pronged approach to clinical development opportunities. Topics covered include, but are not limited to:
  • Steps required to maximize market adoption of your new technology
  • Creating out of the box regulatory strategies that address not only regulatory, but marketing and business needs.
  • Risks and benefits of pursuing general versus specific indication for approval
  • How and when to strategically prepare for publications/scientific evidence and trials that might be required for reimbursement and market adoption.
  • What are the boundaries around promotion? Methods to balance the conservatism of regulatory considerations with the promotion of your product
  • Early medical communication strategies to maximize scientific investments and boost marketing and sales

avatar for Jeannette  Bankes

Jeannette Bankes

Vice President, Global Clinical Research, Communications and Medical Education, Boston Scientific Corp.
24+ years of experience in medical devices and pharmaceuticals 11 years of experience in medical device industry, primarily focused in clinical research and medical affairs 13 years of experience in pharmaceutical industry at Merck & Co. Diverse career portfolio... Read More →

avatar for Eric Ankerud

Eric Ankerud

Executive Vice President, Clinical, Regulatory and Quality, Ocular Therapeutix
Eric Ankerud has more than 25 years of product approval experience covering a wide range of pharmaceuticals, medical devices, and biologics. He joined Ocular Therapeutix in 2007, also serving as Executive Vice President, Clinical, Regulatory and Quality at a sister company Augmenix... Read More →
avatar for Melissa Clark

Melissa Clark

Managing Director, Halloran Consulting
Melissa joined Halloran Consulting Group in 2011. She has 19 years of experience in successful planning and execution of regulatory strategies and clinical trial programs for new product development, developing quality systems, and managing regulatory due diligence and integration... Read More →
avatar for Linda Levitt

Linda Levitt

Senior Director Scientific Communications; Covidien Group at Medtronic, Covidien

Wednesday June 17, 2015 4:00pm - 5:30pm
Boston Scientific Global Headquarters


Networking Reception
Meet new people, connect with old friends and mingle with our speakers at our networking reception. Food and drinks will be served. 

Wednesday June 17, 2015 5:30pm - 6:30pm
Boston Scientific Global Headquarters


Inside the turnaround: An interview with Boston Scientific CEO Mike Mahoney
Our featured event, an in-depth discussion with Boston Scientific CEO Mike Mahoney about his tenure at Boston Scientific. 

avatar for Michael Mahoney

Michael Mahoney

President and CEO, Boston Scientific

Wednesday June 17, 2015 6:30pm - 7:15pm
Boston Scientific Global Headquarters


CEO Panel: Disrupting the continuum of care
MassDevice editor Brad Perriello talks disruptive technologies with Rotation Medical CEO Martha Shadan and Tal Medical CEO Jan Svarka. 

avatar for Martha Shadan

Martha Shadan

President and CEO, Rotation Medical
avatar for Jan Skvarka

Jan Skvarka

CEO, Tal Medical

Wednesday June 17, 2015 7:15pm - 8:00pm
Boston Scientific Global Headquarters


Evening Adjourns
Wednesday June 17, 2015 8:00pm - 8:15pm